Compare BIO & MKSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | MKSI |
|---|---|---|
| Founded | 1952 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Industrial Machinery/Components |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 11.0B |
| IPO Year | N/A | 1999 |
| Metric | BIO | MKSI |
|---|---|---|
| Price | $301.38 | $148.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $358.50 | $154.60 |
| AVG Volume (30 Days) | 163.5K | ★ 856.9K |
| Earning Date | 10-29-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 0.56% |
| EPS Growth | N/A | ★ 820.97 |
| EPS | N/A | ★ 4.12 |
| Revenue | $2,557,500,000.00 | ★ $3,832,000,000.00 |
| Revenue This Year | $1.77 | $10.71 |
| Revenue Next Year | $2.30 | $7.30 |
| P/E Ratio | ★ N/A | $37.95 |
| Revenue Growth | N/A | ★ 8.13 |
| 52 Week Low | $211.43 | $54.84 |
| 52 Week High | $373.69 | $170.37 |
| Indicator | BIO | MKSI |
|---|---|---|
| Relative Strength Index (RSI) | 40.11 | 44.28 |
| Support Level | $298.02 | $153.12 |
| Resistance Level | $319.50 | $160.78 |
| Average True Range (ATR) | 8.25 | 6.11 |
| MACD | -2.09 | -1.68 |
| Stochastic Oscillator | 11.61 | 7.54 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
MKS Inc formerly, MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others, used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.